Camlin Fine Sciences Ltd. reported a consolidated net loss of ₹143.8 million for the September 2025 quarter, despite generating ₹4.6 billion in operational revenue. The loss reflects margin pressures and elevated operating costs in its specialty chemicals and antioxidant segments, amid global demand volatility and input price inflation.
Camlin Fine Sciences Ltd., a leading manufacturer of specialty chemicals and food antioxidants, announced its Q2 FY26 financial results, posting a consolidated net loss of ₹143.8 million. The company’s revenue from operations stood at ₹4.6 billion for the quarter ended September 2025, indicating stable topline performance but continued profitability challenges.
The results come amid global headwinds in raw material pricing and demand fluctuations across key export markets.
Key Highlights From The Earnings Report:
- Revenue of ₹4.6 billion was driven by demand in food preservation, aroma chemicals, and performance materials
- Net loss of ₹143.8 million was attributed to higher input costs and operating expenses
- Margin pressures persisted due to currency volatility and elevated freight and energy costs
- Export volumes remained under stress, particularly in Europe and Latin America
- The company continues to invest in R&D and capacity expansion at Dahej and Ravenna facilities
- Management reaffirmed its focus on cost optimization and product mix realignment to improve margins
- Strategic efforts are underway to strengthen domestic market share and reduce dependency on volatile export regions
Camlin’s Q2 performance reflects the broader challenges faced by specialty chemical firms in balancing growth with cost pressures, while maintaining innovation-led competitiveness.
Sources: Reuters, Economic Times Markets, Camlin Fine Sciences Investor Updates